Documents by category: Abstracts

Low prevalence of pre-treatment HIV-1 drug resistance in Ugandan adults

  • Abstracts
  • Presented at HIV Drug Therapy Glasgow, Scotland (23-26 October 2016)

High rates of multi class drug resistance in HIV-1 infected individuals monitored with CD4 count in Uganda

  • Abstracts
  • Presented at HIV Drug Therapy Glasgow, Scotland (23-26 October 2016)

Low rifampicin and isoniazid concentrations are associated with delayed sputum conversion in HIV positive patients co-infected with tuberculosis in Uganda.

  • Abstracts
  • Presented at HIV Drug Therapy Glasgow, Scotland (23-26 October 2016)

Low isoniazid and rifampicin concentrations in TB/HIV co-infected patients in Uganda

  • Abstracts
  • Presented at HIV Drug Therapy Glasgow (2-6 November 2014)

Association of anti-tuberculosis drug levels serum concentrations with drug-related adverse events in TB/HIV co-infected patients in Uganda

  • Abstracts
  • Presented at European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) (25-28 April 2015)

Importance of continuous monitoring of HIV-infected patients screened for pulmonary tuberculosis – independently of screening results

  • Abstracts
  • Presented at European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) (25-28 April 2015)

High proportion of virological failure and HIV drug resistance among TB/HIV co-infected Ugandan adults

  • Abstracts
  • Presented at European AIDS Clinical Society (EACS) (21-24 October, 2015)

High efavirenz serum concentrations in TB/HIV co-infected Ugandan adults receiving rifampicin-based anti-TB therapy

  • Abstracts
  • Presented at European AIDS Clinical Society (EACS) (21-24 October, 2015)